C07C 67/47
Preparation of carboxylic acid esters: by telomerisation
Official title: by telomerisation (macromolecular compounds C08)
C07C67/47 (Preparation of carboxylic acid esters: by telomerisation) appears on 17 US grants and 26 published applications in this corpus.
Search patents in C07C- Granted patents
- 17
- Published applications
- 26
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 25 Sep 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 7 |
| 2005 | 4 | 3 |
| 2006 | 4 | 0 |
| 2007 | 0 | 8 |
| 2008 | 1 | 3 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 3 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
By publication year.
Recent patents
- Efficient and scalable synthesis of 2-(1′h-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs25 Sep 2018US 10,081,610 B2Ariagen, Inc.
- Compounds for the treatment of metabolic disorders15 Sep 2015US 9,133,073 B2Wellstat Therapeutics Corporation
- Method for the treatment of metabolic disorders10 Dec 2013US 8,604,083 B2Wellstat Therapeutics Corporation
- Methods for the treatment of metabolic disorders such as diabetes8 Oct 2013US 8,552,062 B2Wellstat Therapeutics Corporation
- Compound for the treatment of metabolic disorders16 Jul 2013US 8,487,000 B2Wellstat Therapertics Corporation
- Aryl hydrocarbon receptor modulator19 Sep 2019US 2019/0284149 A1Ariagen, Inc.
- Efficient and scalable synthesis of 2-(1'H-Indole-3'-Carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs21 Mar 2019US 2019/0084948 A1Ariagen, Inc.
- Efficient and scalable synthesis of 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs12 Oct 2017US 2017/0291881 A1AhR Pharmaceuticals, Inc.
- Compounds for the treatment of metabolic disorders24 Oct 2013US 2013/0281705 A1Wellstat Therapeutics Corporation
- Compounds for the treatment of metabolic disorders31 Jan 2008US 2008/0027229 A1Wellstat Therapeutics Corporation
Most cited
By later US patents
- Compounds for the treatment of metabolic disorders40US 6,924,314 B2Wellstat Therapeutics Corporation · 2005
- Compounds for the treatment of metabolic disorders31US 7,012,071 B2Wellstat Therapeutics Corporation · 2006
- Compounds for the treatment of metabolic disorders31US 7,041,659 B2Wellstat Therapeutics Corporation · 2006
- Compounds for the treatment of metabolic disorders30US 7,101,910 B2Wellstat Therapeutics Corporation · 2006
- Compounds for the treatment of metabolic disorders29US 6,858,602 B2Wellstat Therapeutics Corporation · 2005